Clinical Trial Update: A Phase I Study of AK159 in Healthy Postmenopausal Women [Phase 1]

View source ↗

Summary

Phase I trial evaluating AK159 in healthy postmenopausal women with osteoporosis to assess safety and pharmacokinetics has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• AK159

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED